Leidos Holdings is expected to release its fiscal fourth-quarter earnings in mid-February, and analysts project a modest ...

We recently compiled a list of the 10 Best Investments During A Recession. The Cigna Group stands sixth on our list among the ...

NOOGI, a South Korean health-tech pioneer, introduces AI-driven posture care systems and patented seat technology to combat ...

Detailed price information for Lockheed Martin Corp (LMT-N) from The Globe and Mail including charting and trades.

The gathering underscored a growing consensus: standardization is the missing infrastructure layer needed to unlock ...

Detailed price information for Predictmedix AI Inc (PMEDF) from The Globe and Mail including charting and trades.

Leidos trades at $183.35 and has moved in lockstep with the market. Its shares have returned 16.2% over the last six months while the S&P 500 has gained 11.3%.

As such, the results demonstrate that our oral gel platform enhances the delivery of lipophilic cannabinoid molecules and delivers more efficient uptake in the body. These results create a clear ...

The gene therapy market is surging toward $36.55 billion by 2032, powered by rising demand for curative treatments that target genetic diseases at their source([1]) . The FDA approved three ...

Jopari AttachInsights and Jopari RiskReview extend company’s end-to-end claims processing platformCONCORD, Calif.--(BUSINESS ...

Appointment Supports AIML's Commercial Execution and Operational Scale as the Company Advances Its AI-Driven Cardiac Platform Leadership Addition Aligns Revenue, Delivery, and Product Execution as ...